We are live on ! Find out more
MR

MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR

Delisted

MR was delisted on the 3rd of March, 2016.

131 hedge funds and large institutions have $2.9B invested in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

4% less capital invested

Capital invested by funds: $3.02B → $2.9B (-$120M)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

14% less funds holding

Funds holding: 153131 (-22)

41% less call options, than puts

Call options by funds: $16.2M | Put options by funds: $27.5M

73% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 30

Holders
131
Holders Change
-22
Holders Change %
-14.38%
% of All Funds
3.76%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
8
Increased
51
Reduced
44
Closed
30
Calls
$16.2M
Puts
$27.5M
Net Calls
-$11.3M
Net Calls Change
-$702K
Name Holding Trade Value Shares
Change
Change in
Stake
GA
101
Geneva Advisors
Illinois
$395K +$398K +12,545 New
PTA
102
Pear Tree Advisors
Massachusetts
$392K
AAM
103
Advisors Asset Management
Colorado
$392K +$36K +1,134 +10%
ARTA
104
A.R.T. Advisors
New York
$350K -$2.55M -80,230 -88%
TG
105
TCW Group
California
$333K
Zurich Cantonal Bank
106
Zurich Cantonal Bank
Switzerland
$284K
RBC
107
Ronald Blue & Co
Georgia
$277K +$29.5K +928 +12%
Wellington Management Group
108
Wellington Management Group
Massachusetts
$258K -$9.52K -300 -4%
NG
109
NatWest Group
United Kingdom
$227K +$229K +7,200 New
Comerica Bank
110
Comerica Bank
Texas
$220K -$45.7K -1,440 -17%
FA
111
FDx Advisors
Illinois
$201K +$202K +6,367 New
Bank of America
112
Bank of America
North Carolina
$200K +$32.9K +1,037 +20%
HTI
113
Hikari Tsushin Inc
Japan
$129K
WTB
114
Washington Trust Bank
Washington
$116K
US Bancorp
115
US Bancorp
Minnesota
$73K -$2.7K -85 -4%
Envestnet Asset Management
116
Envestnet Asset Management
Illinois
$57K -$6.89K -217 -11%
GXMC
117
Global X Management Company
New York
$51K +$24.7K +778 +91%
CLOS
118
Compagnie Lombard Odier SCmA
Switzerland
$38K
Canada Pension Plan Investment Board
119
Canada Pension Plan Investment Board
Ontario, Canada
$27K -$222K -7,000 -89%
KTC
120
Kistler-Tiffany Companies
Pennsylvania
$22K
IMS
121
Index Management Solutions
Pennsylvania
$21K +$2.32K +73 +12%
FHA
122
First Horizon Advisors
Tennessee
$16K
BCAM
123
Boston Common Asset Management
Massachusetts
$13K -$1.5M -47,235 -99%
ECM
124
Estabrook Capital Management
New York
$12.6K
BFA
125
BlackRock Fund Advisors
California
$10K

MR Hedge Fund Activity: Q2 2014 in Review

131 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) for Q2 2014, worth a combined $2.9B — down 4% from $3.02B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of MR and 8 opened new positions — a net loss of 22 holders — while 44 trimmed existing stakes and 51 added.

The largest buyer was OppenheimerFunds, adding an estimated $49.2M. The largest seller was CI Investments Inc, exiting entirely with an estimated $71.3M sold.

  • 131 institutional investors held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) as of Q2 2014, down from 153 in Q1 2014.
  • Funds reported $2.9B of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A stock for Q2 2014, down 4% quarter-over-quarter.
  • 8 funds opened new MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A positions in Q2 2014 and 30 closed out, a net change of -22 holders.
  • The largest MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A buyer in Q2 2014 was OppenheimerFunds, an estimated $49.2M added.
  • The largest MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A seller in Q2 2014 was CI Investments Inc, an estimated $71.3M sold.

Based on aggregated 13F filings for Q2 2014.